ロード中...
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis
OBJECTIVES: We aimed to assess the expression of the CCL24 chemokine in systemic sclerosis (SSc) and to evaluate the possible pathogenic implications of the CCL24/CCR3 axis using both in vitro and in vivo models. We further investigated the efficacy of an anti-CCL24 monoclonal antibody (mAb), CM-101...
保存先:
| 出版年: | Ann Rheum Dis |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788878/ https://ncbi.nlm.nih.gov/pubmed/31129606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2019-215119 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|